Ospri

Executive Summary

Ospri is a San Diego-based private diagnostics company founded in 2020, specializing in multiplex molecular assays designed to simplify and expedite laboratory testing. Their advanced reagents enable labs to achieve faster results with fewer steps, targeting both new lab setups and workflow upgrades. The company's focus on multiplexing positions it within the growing demand for efficient, high-throughput diagnostic solutions. Despite limited public information on funding or stage, Ospri's technology addresses key pain points in clinical diagnostics, such as turnaround time and operational complexity. Its early-stage status suggests potential for growth as it seeks to commercialize its platform and establish a foothold in the competitive molecular diagnostics market.

Upcoming Catalysts (preview)

• Q4 2026Launch of First Commercial Multiplex Assay Panel60% success
• Q2 2027Strategic Partnership with a Major Diagnostic Distributor40% success
• Q3 2026Series A Funding Round50% success